Filing Details

Accession Number:
0001873919-24-000001
Form Type:
4
Zero Holdings:
No
Publication Time:
2024-10-03 18:19:19
Reporting Period:
2024-10-01
Accepted Time:
2024-10-03 18:19:19
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1841387 Candel Therapeutics Inc. CADL Biological Products, (No Disgnostic Substances) (2836) 522214851
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1873915 K. Laura Aguilar 160 Paulson Rd.
Waban MA 02468
No No Yes No
1873919 Estuardo Aguilar-Cordova 160 Paulson Rd.
Waban MA 02468
No No Yes No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Cadl Acquisiton 2024-10-01 6,214 $7.01 988,661 No 4 S Direct
Cadl Disposition 2024-10-02 26,988 $6.92 961,673 No 4 S Direct
Cadl Disposition 2024-10-03 1,800 $6.85 959,873 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Direct
No 4 S Direct
No 4 S Direct
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Cadl 2,074,942 Indirect By Estuardo Aguilar-Cordova 2020 Irrevocable Trust
Cadl 2,013,100 Indirect By Laura K. Aguilar 2020 Irrevocable Trust
Cadl 874,943 Indirect Laura K. Aguilar
Cadl 171,335 Direct
Footnotes
  1. Shares of common stock held by spouse irrevocable trust
  2. Shares of common stock held by spouse LKA 2022 revocable trust
  3. Shares of common stock held jointly with spouse